United States · FDA National Drug Code directory

Carbidopa and Levodopa

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 77771-460_2122b915-f36b-40d3-aaba-c50a3e8229c6
Product NDC: 77771-460
Form: TABLET, EXTENDED RELEASE
Composition / generic term: Carbidopa and Levodopa
Labeler: Radha Pharmaceuticals Inc
Marketing category: ANDA
Marketing start / end (source format): 20250425
Source listing expiry: 20271231

Source-listed ingredients

CARBIDOPA — 25 mg/1
LEVODOPA — 100 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

100 TABLET, EXTENDED RELEASE in 1 BOTTLE (77771-460-01) · 77771-460-01

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →